Literature DB >> 14605986

Gastrointestinal mucositis: a new biological model.

Dorothy M K Keefe1.   

Abstract

The history of research into gastrointestinal mucositis (GIM), and how the future directions are informed by the progress made in the study of oral mucositis (OM) are discussed. It is proposed that OM and GIM should both be considered to be elements of alimentary mucositis (AM), which covers mucosal damage through the entire alimentary tract, with regional differences being due to the specialized needs of each area.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14605986     DOI: 10.1007/s00520-003-0550-9

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  9 in total

1.  Morphologic alterations induced by methotrexate in the mucosa of human proximal intestine. I. Serial observations by light microscopy.

Authors:  J S TRIER
Journal:  Gastroenterology       Date:  1962-03       Impact factor: 22.682

2.  Morphologic alterations induced by methotrexate in the mucosa of human proximal intestine. II. Electron microscopic observations.

Authors:  J S TRIER
Journal:  Gastroenterology       Date:  1962-10       Impact factor: 22.682

3.  Effect of high-dose chemotherapy on intestinal permeability in humans.

Authors:  D M Keefe; A G Cummins; B M Dale; D Kotasek; T A Robb; R E Sage
Journal:  Clin Sci (Lond)       Date:  1997-04       Impact factor: 6.124

4.  Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans.

Authors:  D M Keefe; J Brealey; G J Goland; A G Cummins
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

5.  Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.

Authors:  Rachel J Gibson; Joanne M Bowen; Mark R B Inglis; Adrian G Cummins; Dorothy M K Keefe
Journal:  J Gastroenterol Hepatol       Date:  2003-09       Impact factor: 4.029

6.  Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats.

Authors:  Rachel J Gibson; Dorothy M K Keefe; Fiona M Thompson; Julie M Clarke; Gary J Goland; Adrian G Cummins
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

Review 7.  Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity.

Authors:  S T Sonis
Journal:  Oral Oncol       Date:  1998-01       Impact factor: 5.337

8.  The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer.

Authors:  Rachel J Gibson; Dorothy M K Keefe; Julie M Clarke; Geoff O Regester; Fiona M Thompson; Gary J Goland; Ben G Edwards; Adrian G Cummins
Journal:  Cancer Chemother Pharmacol       Date:  2002-05-14       Impact factor: 3.333

9.  Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum.

Authors:  N Ikuno; H Soda; M Watanabe; M Oka
Journal:  J Natl Cancer Inst       Date:  1995-12-20       Impact factor: 13.506

  9 in total
  24 in total

Review 1.  Oral mucositis: the new paradigms.

Authors:  Douglas E Peterson; Rajesh V Lalla
Journal:  Curr Opin Oncol       Date:  2010-07       Impact factor: 3.645

2.  Live and heat-killed Lactobacillus rhamnosus GG upregulate gene expression of pro-inflammatory cytokines in 5-fluorouracil-pretreated Caco-2 cells.

Authors:  Shiuh-Bin Fang; Hsin-Yu Shih; Chih-Hung Huang; Li-Ting Li; Chia-Chun Chen; Hsu-Wei Fang
Journal:  Support Care Cancer       Date:  2014-02-06       Impact factor: 3.603

Review 3.  Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice.

Authors:  Douglas E Peterson; Dorothy M Keefe; Ronald D Hutchins; Mark M Schubert
Journal:  Support Care Cancer       Date:  2006-04-26       Impact factor: 3.603

4.  Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines.

Authors:  Joanne M Bowen; Rachel J Gibson; Janet K Coller; Nicole Blijlevens; Paolo Bossi; Noor Al-Dasooqi; Emma H Bateman; Karen Chiang; Charlotte de Mooij; Bronwen Mayo; Andrea M Stringer; Wim Tissing; Hannah R Wardill; Ysabella Z A van Sebille; Vinisha Ranna; Anusha Vaddi; Dorothy Mk Keefe; Rajesh V Lalla; Karis Kin Fong Cheng; Sharon Elad
Journal:  Support Care Cancer       Date:  2019-07-08       Impact factor: 3.603

Review 5.  Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.

Authors:  Rachel J Gibson; Dorothy M K Keefe; Rajesh V Lalla; Emma Bateman; Nicole Blijlevens; Margot Fijlstra; Emily E King; Andrea M Stringer; Walter J F M van der Velden; Roger Yazbeck; Sharon Elad; Joanne M Bowen
Journal:  Support Care Cancer       Date:  2012-11-10       Impact factor: 3.603

Review 6.  Dark Agouti rat model of chemotherapy-induced mucositis: establishment and current state of the art.

Authors:  Barbara Vanhoecke; Emma Bateman; Bronwen Mayo; Eline Vanlancker; Andrea Stringer; Daniel Thorpe; Dorothy Keefe
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

Review 7.  Intestinal mucositis: the role of the Bcl-2 family, p53 and caspases in chemotherapy-induced damage.

Authors:  Joanne M Bowen; Rachel J Gibson; Adrian G Cummins; Dorothy M K Keefe
Journal:  Support Care Cancer       Date:  2006-02-02       Impact factor: 3.603

Review 8.  Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.

Authors:  Ysabella Z A Van Sebille; Romany Stansborough; Hannah R Wardill; Emma Bateman; Rachel J Gibson; Dorothy M Keefe
Journal:  Curr Oncol Rep       Date:  2015-11       Impact factor: 5.075

9.  Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study.

Authors:  Noor Al-Dasooqi; Joanne Bowen; Colin Bennett; John Finnie; Dorothy Keefe; Rachel Gibson
Journal:  Support Care Cancer       Date:  2016-09-20       Impact factor: 3.603

10.  New pathways for alimentary mucositis.

Authors:  Joanne M Bowen; Dorothy M K Keefe
Journal:  J Oncol       Date:  2008-09-23       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.